{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T20:38:29Z","timestamp":1757623109754,"version":"3.44.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T00:00:00Z","timestamp":1755043200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T00:00:00Z","timestamp":1755043200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Inform Decis Mak"],"DOI":"10.1186\/s12911-025-03097-2","type":"journal-article","created":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T10:23:21Z","timestamp":1755080601000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hypercubes to identify geomarkers of rapid cystic fibrosis lung disease progression"],"prefix":"10.1186","volume":"25","author":[{"given":"Yizi","family":"Cheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cole","family":"Brokamp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erika Rasnick","family":"Manning","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth L.","family":"Kramer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick H.","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rhonda D.","family":"Szczesniak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emrah","family":"Gecili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,13]]},"reference":[{"issue":"4","key":"3097_CR1","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1016\/j.jpeds.2013.05.013","volume":"163","author":"WJ Morgan","year":"2013","unstructured":"Morgan WJ, Wagener JS, Yegin A, et al. Probability of treatment following acute decline in lung function in children with cystic fibrosis is related to baseline pulmonary function. J Pediatr. 2013;163(4):1152\u20137.e2. https:\/\/doi.org\/10.1016\/j.jpeds.2013.05.013.","journal-title":"J Pediatr"},{"issue":"2","key":"3097_CR2","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1002\/ppul.21526","volume":"47","author":"SL Vandenbranden","year":"2012","unstructured":"Vandenbranden SL, McMullen A, Schechter MS, et al. Lung function decline from adolescence to young adulthood in cystic fibrosis. Pediatr Pulmonol. 2012;47(2):135\u201343. https:\/\/doi.org\/10.1002\/ppul.21526.","journal-title":"Pediatr Pulmonol"},{"issue":"4","key":"3097_CR3","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1164\/rccm.201612-2574OC","volume":"196","author":"RD Szczesniak","year":"2017","unstructured":"Szczesniak RD, Li D, Su W, et al. Phenotypes of rapid cystic fibrosis lung disease progression during adolescence and young adulthood. Am J Respir Crit Care Med. 2017;196(4):471\u201378. https:\/\/doi.org\/10.1164\/rccm.201612-2574OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"3097_CR4","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1513\/AnnalsATS.202209-829OC","volume":"20","author":"R Szczesniak","year":"2023","unstructured":"Szczesniak R, Andrinopoulou ER, Su W, et al. Lung function decline in cystic fibrosis: impact of data availability and modeling strategies on clinical interpretations. Ann Am Thorac Soc. 2023;20(7):958\u201368. https:\/\/doi.org\/10.1513\/AnnalsATS.202209-829OC.","journal-title":"Ann Am Thorac Soc"},{"issue":"1","key":"3097_CR5","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1002\/ppul.21325","volume":"46","author":"GS Sawicki","year":"2011","unstructured":"Sawicki GS, Rasouliyan L, McMullen AH, et al. Longitudinal assessment of health-related quality of life in an observational cohort of patients with cystic fibrosis. Pediatr Pulmonol. 2011;46(1):36\u201344. https:\/\/doi.org\/10.1002\/ppul.21325.","journal-title":"Pediatr Pulmonol"},{"issue":"7","key":"3097_CR6","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1080\/17476348.2020.1753507","volume":"14","author":"R Szczesniak","year":"2020","unstructured":"Szczesniak R, Rice JL, Brokamp C, et al. Influences of environmental exposures on individuals living with cystic fibrosis. Expert Rev Respir Med. 2020;14(7):737\u201348. https:\/\/doi.org\/10.1080\/17476348.2020.1753507.","journal-title":"Expert Rev Respir Med"},{"issue":"32","key":"3097_CR7","doi-asserted-by":"publisher","first-page":"8592","DOI":"10.1073\/pnas.1703764114","volume":"114","author":"DR Cox","year":"2017","unstructured":"Cox DR, Battey HS. Large numbers of explanatory variables, a semi-descriptive analysis. Proc Natl Acad Sci U S A. 2017;114(32):8592\u201395. https:\/\/doi.org\/10.1073\/pnas.1703764114.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"3097_CR8","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1513\/AnnalsATS.201511-781OC","volume":"13","author":"EA Knapp","year":"2016","unstructured":"Knapp EA, Fink AK, Goss CH, et al. The cystic fibrosis foundation patient registry. Design and methods of a national observational disease registry. Ann Am Thorac Soc. 2016;13(7):1173\u201379. https:\/\/doi.org\/10.1513\/AnnalsATS.201511-781OC.","journal-title":"Ann Am Thorac Soc"},{"issue":"5","key":"3097_CR9","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1002\/ppul.26352","volume":"58","author":"E Gecili","year":"2023","unstructured":"Gecili E, Brokamp C, Rasnick E, et al. Built environment factors predictive of early rapid lung function decline in cystic fibrosis. Pediatr Pulmonol. 2023;58(5):1501\u201313. https:\/\/doi.org\/10.1002\/ppul.26352.","journal-title":"Pediatr Pulmonol"},{"key":"3097_CR10","doi-asserted-by":"publisher","first-page":"100449","DOI":"10.1016\/j.envadv.2023.100449","volume":"14","author":"AK Palipana","year":"2023","unstructured":"Palipana AK, Vancil A, Gecili E, et al. Social-environmental phenotypes of rapid cystic fibrosis lung disease progression in adolescents and young adults living in the United States. Environ Adv. 2023;14:100449. https:\/\/doi.org\/10.1016\/j.envadv.2023.100449.","journal-title":"Environ Adv"},{"issue":"3","key":"3097_CR11","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1093\/biostatistics\/kxu053","volume":"16","author":"PJ Diggle","year":"2015","unstructured":"Diggle PJ, Sousa I, Asar \u00d6. Real-time monitoring of progression towards renal failure in primary care patients. Biostatistics. 2015;16(3):522\u201336. https:\/\/doi.org\/10.1093\/biostatistics\/kxu053.","journal-title":"Biostatistics"},{"issue":"6","key":"3097_CR12","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1002\/sim.8443","volume":"39","author":"RD Szczesniak","year":"2020","unstructured":"Szczesniak RD, Su W, Brokamp C, et al. Dynamic predictive probabilities to monitor rapid cystic fibrosis disease progression. Stat Med. 2020;39(6):740\u201356. https:\/\/doi.org\/10.1002\/sim.8443.","journal-title":"Stat Med"},{"issue":"10","key":"3097_CR13","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1136\/thoraxjnl-2011-200953","volume":"67","author":"D Taylor-Robinson","year":"2012","unstructured":"Taylor-Robinson D, Whitehead M, Diderichsen F, et al. Understanding the natural progression in %FEV1 decline in patients with cystic fibrosis: a longitudinal study. Thorax. 2012;67(10):860\u201366. https:\/\/doi.org\/10.1136\/thoraxjnl-2011-200953.","journal-title":"Thorax"},{"issue":"12","key":"3097_CR14","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.annepidem.2013.08.009","volume":"23","author":"RD Szczesniak","year":"2013","unstructured":"Szczesniak RD, McPhail GL, Duan LL, Macaluso M, Amin RS, Clancy JP. A semiparametric approach to estimate rapid lung function decline in cystic fibrosis. Ann Epidemiol. 2013;23(12):771\u201377. https:\/\/doi.org\/10.1016\/j.annepidem.2013.08.009.","journal-title":"Ann Epidemiol"},{"issue":"3","key":"3097_CR15","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1080\/19466315.2020.1870546","volume":"13","author":"W Su","year":"2021","unstructured":"Su W, Gecili E, Wang X, Szczesniak RD. An empirical comparison of segmented and stochastic linear mixed effects models to estimate rapid disease progression in longitudinal biomarker studies. Stat Biopharm Res. 2021;13(3):270\u201379. https:\/\/doi.org\/10.1080\/19466315.2020.1870546.","journal-title":"Stat Biopharm Res"},{"issue":"6","key":"3097_CR16","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1183\/09031936.00080312","volume":"40","author":"PH Quanjer","year":"2012","unstructured":"Quanjer PH, Stanojevic S, Cole TJ, et al. Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations. Eur Respir J. 2012;40(6):1324\u201343. https:\/\/doi.org\/10.1183\/09031936.00080312.","journal-title":"Eur Respir J"},{"key":"3097_CR17","doi-asserted-by":"publisher","unstructured":"Hoeltgebaum HH, Battey H. HCmodelSets: An R package for specifying sets of well-fitting models in high dimensions. The R J. 2020;11(2):370\u201379. https:\/\/doi.org\/10.32614\/RJ-2019-057.","DOI":"10.32614\/RJ-2019-057"},{"key":"3097_CR18","doi-asserted-by":"publisher","first-page":"e2884","DOI":"10.1002\/env.2884","volume":"36","author":"E Gecili","year":"2025","unstructured":"Gecili E, Brokamp C, Asar \u00d6, Andrinopoulou E-R, Brewington JJ, Szczesniak RD. Spike and slab regression for nonstationary gaussian linear mixed effects modeling of rapid disease progression. Environmetrics. 2025;36:e2884. https:\/\/doi.org\/10.1002\/env.2884.","journal-title":"Environmetrics"},{"key":"3097_CR19","first-page":"342","volume":"55","author":"C Siracusa","year":"2020","unstructured":"Siracusa C, Leonardn D, Mack J, et al. Implementing and adapting FEV1-indicated exacerbation signal algorithms through quality improvement. Pediatr Pulmonol. 2020;55:342.","journal-title":"Pediatr Pulmonol"},{"key":"3097_CR20","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.annepidem.2018.11.008","volume":"30","author":"C Brokamp","year":"2019","unstructured":"Brokamp C, Beck AF, Goyal NK, Ryan P, Greenberg JM, Hall ES. Material community deprivation and hospital utilization during the first year of life: an urban population-based cohort study. Ann Epidemiol. 2019;30:37\u201343. https:\/\/doi.org\/10.1016\/j.annepidem.2018.11.008.","journal-title":"Ann Epidemiol"},{"issue":"450\u2013451","key":"3097_CR21","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.scitotenv.2013.01.074","volume":"15","author":"K Zhang","year":"2013","unstructured":"Zhang K, Batterman S. Air pollution and health risks due to vehicle traffic. Sci Total Environ. 2013, Apr;15(450\u2013451):307\u201316. https:\/\/doi.org\/10.1016\/j.scitotenv.2013.01.074. PMID: 23500830; PMCID: PMC4243514.","journal-title":"Sci Total Environ"},{"issue":"23","key":"3097_CR22","doi-asserted-by":"publisher","first-page":"7024","DOI":"10.1093\/nar\/gkg894","volume":"31","author":"N Banerjee","year":"2003","unstructured":"Banerjee N, Zhang MQ. Identifying cooperativity among transcription factors controlling the cell cycle in yeast. Nucleic Acids Res. 2003;31(23):7024\u201331. https:\/\/doi.org\/10.1093\/nar\/gkg894.","journal-title":"Nucleic Acids Res"},{"issue":"38","key":"3097_CR23","doi-asserted-by":"publisher","first-page":"13532","DOI":"10.1073\/pnas.0505874102","volume":"102","author":"HK Tsai","year":"2005","unstructured":"Tsai HK, Lu HH, Li WH. Statistical methods for identifying yeast cell cycle transcription factors. Proc Natl Acad Sci U S A. 2005;102(38):13532\u201337. https:\/\/doi.org\/10.1073\/pnas.0505874102.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"3097_CR24","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1002\/sim.9279","volume":"41","author":"E Gecili","year":"2022","unstructured":"Gecili E, Sivaganesan S, Asar O, Clancy JP, Ziady A, Szczesniak RD. Bayesian regularization for a nonstationary Gaussian linear mixed effects model. Stat Med. 2022;41(4):681\u201397. https:\/\/doi.org\/10.1002\/sim.9279.","journal-title":"Stat Med"},{"key":"3097_CR25","doi-asserted-by":"publisher","first-page":"145905","DOI":"10.1016\/j.scitotenv.2021.145905","volume":"776","author":"E Gecili","year":"2021","unstructured":"Gecili E, Brokamp C, Palipana A, et al. Seasonal variation of lung function in cystic fibrosis: longitudinal modeling to compare a Midwest US cohort to international populations. Sci Total Environ. 2021;776:145905.","journal-title":"Sci Total Environ"},{"issue":"3","key":"3097_CR26","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.jcf.2018.10.006","volume":"18","author":"T Qvist","year":"2019","unstructured":"Qvist T, Schl\u00fcter DK, Rajabzadeh V, et al. Seasonal fluctuation of lung function in cystic fibrosis: A national register-based study in two northern European populations. J Cyst Fibros. 2019;18(3):390\u201395. https:\/\/doi.org\/10.1016\/j.jcf.2018.10.006.","journal-title":"J Cyst Fibros"},{"issue":"5","key":"3097_CR27","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1164\/rccm.202108-1986OC","volume":"205","author":"DP Nichols","year":"2022","unstructured":"Nichols DP, Paynter AC, Heltshe SL, Donaldson SH, Frederick CA, Freedman SD, Gelfond D, Hoffman LR, Kelly A, Narkewicz MR, Pittman JE, Ratjen F, Rosenfeld M, Sagel SD, Schwarzenberg SJ, Singh PK, Solomon GM, Stalvey MS, Clancy JP, Kirby S, Van Dalfsen JM, Kloster MH, Rowe SM, PROMISE Study group. Clinical effectiveness of elexacaftor\/tezacaftor\/ivacaftor in people with cystic fibrosis: a clinical trial. Am J Respir Crit Care Med. 2022, Mar, 1;205(5):529\u201339. https:\/\/doi.org\/10.1164\/rccm.202108-1986OC. PMID: 34784492; PMCID: PMC8906485.","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"3097_CR28","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1002\/ppul.25859","volume":"57","author":"E Kramer-Golinkoff","year":"2022","unstructured":"Kramer-Golinkoff E, Camacho A, Kramer L, Taylor-Cousar JL. A survey: Understanding the health and perspectives of people with CF not benefiting from CFTR modulators. Pediatr Pulmonol. 2022, May;57(5):1253\u201361. https:\/\/doi.org\/10.1002\/ppul.25859. Epub 2022 Mar 28. PMID: 35170259; PMCID: PMC9314897.","journal-title":"Pediatr Pulmonol"},{"issue":"5","key":"3097_CR29","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1111\/rssc.12405","volume":"69","author":"O Asar","year":"2020","unstructured":"Asar O, Bolin D, Diggle PJ, et al. Linear mixed effects models for non-gaussian continuous repeated measurement data. J R Stat Soc Ser C Appl Stat. 2020, November;69(5):1015\u201365. https:\/\/doi.org\/10.1111\/rssc.12405.","journal-title":"J R Stat Soc Ser C Appl Stat"}],"container-title":["BMC Medical Informatics and Decision Making"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12911-025-03097-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12911-025-03097-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12911-025-03097-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T02:06:43Z","timestamp":1757383603000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedinformdecismak.biomedcentral.com\/articles\/10.1186\/s12911-025-03097-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,13]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3097"],"URL":"https:\/\/doi.org\/10.1186\/s12911-025-03097-2","relation":{},"ISSN":["1472-6947"],"issn-type":[{"type":"electronic","value":"1472-6947"}],"subject":[],"published":{"date-parts":[[2025,8,13]]},"assertion":[{"value":"6 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Cincinnati Children\u2019s Hospital Medical Center\u2019s Institutional Review Board (IRB #: 2018\u20134839) as exempt research. The Cincinnati Children\u2019s Hospital Medical Center\u2019s Institutional Review Board has granted an exemption from requiring informed consent due to the retrospective nature of the study. All methods were carried out in accordance with relevant guidelines and regulations. This study was also approved by the Cystic Fibrosis Foundation Patient Registry (CFFPR) Committee. The CFFPR collects information on the health status of people with cystic fibrosis who receive care in Cystic Fibrosis Foundation-accredited care centers and agree to participate in the CFFPR.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"304"}}